相关实验视频
Updated: Jan 16, 2026

07:01
A New Portable In Vitro Exposure Cassette for Aerosol Sampling
Published on: February 22, 2019
7.6K
颗粒结合的基和多基物质的体外吸入生物可用性:影响因素和风险评估
Bin Wang1, Yiming Yao2,3, Hongwen Sun4
1College of Resources and Environmental Engineering, Key Laboratory of Karst Georesources and Environment, Ministry of Education, Guizhou University, Guiyang, 550025, China.
Environmental geochemistry and health
|September 27, 2025
概括
在大气颗粒物 (APM) 中吸入的per-和多基物质 (PFAS) 在模拟的肺液中显示出高生物可用性. 忽视这种生物可用性可能会高估吸入PFAS的健康风险.
科学领域:
- 环境科学 环境科学
- 毒理学 毒理学 毒理学
- 公共卫生 公共卫生
背景情况:
- 人们越来越担心大气颗粒物 (APM) 中吸入的多基和多基物质 (PFAS).
- 了解PFAS在肺部的生物可用性对于准确的健康风险评估至关重要.
研究的目的:
- 用模拟的肺液来研究PFAS在不同尺寸的APM中的生物可用性.
- 确定APM大小和PFAS特性对吸入生物可用性的影响.
主要方法:
- 收集和分析APM样本 (PM1.0,PM2.5,PM10) 检测PFAS度.
- 使用修改的甘布尔溶液 (MGS) 和人工溶酶体液 (ALF) 的体外模拟来评估PFAS的生物可用性.
- 在1天的潜伏期内测量吸入生物利用率分数 (IBAFs).
主要成果:
- 在PM1.0和PM2.5中,PFAS度明显高于PM10.
- 在MGS和ALF中,PFAS表现出高的IBAF,在1天内达到平衡.
- APM大小和PFAS疏水性影响IBAFs;ALF中的生物可用性高于MGS.
结论:
- 在APM中的PFAS具有很高的吸入生物可用性,受颗粒大小和化学性质的影响.
- 如果不考虑生物可用性,可能会使吸入PFAS的健康风险高估17-47%.
相关概念视频
Bioavailability: Influencing Factors
340
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
340
Factors Influencing Bioavailability: First-Pass Elimination
7.9K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
7.9K
Drug Product Performance: In Vitro–In Vivo Correlation
230
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
230
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
183
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
183
Bioavailability: Overview
4.2K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
4.2K
Bioavailability: Overview
368
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
368

